Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

ATP Synthase: Mechanism

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...

The Inner Mitochondrial Membrane

The Inner Mitochondrial Membrane

The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interpretable machine learning framework for frailty risk prediction using NHANES 2007-2018: A cross-sectional study.

Medicine·2026

Same author

Effect of combined aspirin and statin therapy on mortality reduction in sepsis-induced myocardial injury.

Frontiers in pharmacology·2026

Same author

Biomimetic MXene nanoplatform for tumor-specific synergistic phototherapy and immune reprogramming in pancreatic cancer.

Biomaterials science·2026

Same author

Enforced BATF expression via clinically approved LNPs enhances adoptive T-cell therapies.

Blood science (Baltimore, Md.)·2026

Same author

Sequential in vivo CRISPR screens identify the clonal dominance of <i>Nf1</i> loss in long-term hematopoiesis.

Blood science (Baltimore, Md.)·2026

Same author

The dual role of the CXCL9/10/11-CXCR3 axis in the tumor immune microenvironment: Mechanisms, therapeutic implications, and clinical translation.

Pharmacological research·2026

Search research articles

Related Experiment Video

Updated: May 29, 2026

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

Platelet Mitochondria: A Promising Target for Antiplatelet Therapy.

Yan-Zhu Yao¹, Tong Yin¹, Yong-Ming Yao²

¹Institute of Geriatrics, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatric Diseases, Second Medical Center of the Chinese PLA General Hospital, Beijing, China.

Antioxidants & Redox Signaling

|May 27, 2026

Summary

Platelet mitochondria are crucial for blood clot formation and activation. Targeting platelet metabolism offers a promising new strategy to prevent thrombosis while minimizing bleeding risks associated with current therapies.

Keywords:

antiplatelet targets platelet activation platelet mitochondria

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 29, 2026

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Area of Science:

Mitochondrial biology
Hematology
Thrombosis research

Background:

Platelet mitochondria play a key role in platelet activation and thrombosis.
Mechanisms include metabolic reprogramming, calcium signaling, and quality control.
Mitochondrial genome (mtDNA) regulation is linked to various diseases.

Purpose of the Study:

To summarize key platelet mitochondrial mechanisms driving platelet activation.
To highlight the role of metabolic reprogramming, calcium flux, quality control, and mtDNA.
To discuss challenges and future directions in targeting platelet mitochondria.

Main Methods:

Literature review and summary of current research on platelet mitochondrial function.
Analysis of metabolic pathways, including oxidative phosphorylation (OXPHOS) and glycolysis.
Discussion of mitochondrial dynamics, mitophagy, and mtDNA regulation.

Main Results:

Platelet mitochondria fuel energy demands via metabolic reprogramming, regulate calcium signaling, and maintain integrity through quality control.
The role of OXPHOS in thrombosis is complex and not fully understood.
Metabolic flexibility and cytotoxic effects of modulators pose therapeutic challenges.

Conclusions:

Targeting platelet mitochondria with antioxidants and metabolic modulators is a promising antiplatelet strategy.
Further research into platelet-derived mitochondria transplantation and mtDNA detection is warranted.
Developing metabolism-targeting therapies could overcome limitations of current antiplatelet agents.